Posted by Michael Wonder on 27 Feb 2022
Health Canada authorises Medicago COVID-19 vaccine for adults 18 to 64 years of age
25 February 2022 - Today, Health Canada authorised Medicago's Covifenz COVID-19 vaccine for the prevention of COVID-19 in adults 18 to 64 years of age.
After a thorough and independent scientific review of the evidence, the Department has determined that the vaccine meets Health Canada's stringent safety, efficacy and quality requirements, and that the benefits of this vaccine outweigh the potential risks.
